An observational study in Bradycardia Sinus, AV Block and Atrial Fibrillation (AF), sponsored by Medtronic Cardiac Rhythm and Heart Failure. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Medtronic Cardiac Rhythm and Heart Failure (part of Medtronic) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Atrioventricular Block with a site in China — 5 open to participants now, 6 under way, none of them phase 3. Atrioventricular Block · China.
Among the 15 studies in Atrioventricular Block with a site in China, this one is the only one that started in 2025, is one of 7 observational ones, and was the 13th registered.
118 studies on the registry are indexed under Atrioventricular Block; 44 are open to participants now.
Browse Atrioventricular Block studies →5 of the 15 studies in Atrioventricular Block with a site in China are open now. Recruiting first, the newest first:
Min Shen · Sites in China
Ages 18–85
The Third People's Hospital of Chengdu · Sites in China
Ages 18+
Peking Union Medical College Hospital · Sites in China
Ages 18–85
Ningbo No.2 Hospital · Sites in China
Xiaohan Fan · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 29 Atrioventricular Block studies recruiting now, 21 (72%) set no upper age limit and 4 (14%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 1 started in 2025.
This study's enrollment of 41 is below the median of 300 across 37 observational studies indexed under Atrioventricular Block.
Median enrollment 387 across the 8 interventional studies, 60 across the 7 observational. Of the 4 that completed or were terminated, 1 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 15 have an industry lead sponsor. The 10 most frequent:
This study is registered under Medtronic Cardiac Rhythm and Heart Failure, one of the names counted as Medtronic. Under that name alone:
Medtronic Cardiac Rhythm and Heart Failure is the lead sponsor of 240 studies on the registry; 4 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 18 (95%) have results posted.
Medtronic has 9 studies filed under Atrioventricular Block — fewer than ten, so there is no comparison to draw.
2 of the studies in Atrioventricular Block with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07378124Ningbo No.2 HospitalLLL vs. SDL for LBBP: A Non-inferiority RCT | 2027-06-30 |
| NCT07802119Min ShenTransjugular Approach for Implantation of Active Fixation Leadless Pacemakers | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 15 studies in Atrioventricular Block with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to assess inter-/intra- ventricular synchrony and ECG characteristics in relation to Micra tip location.
The secondary objective is (1) to identify an optimal Micra pacing location to improve LV function, (2) to investigate the correlation between Micra tip location and tricuspid regurgitation, and (3) to investigate whether Micra location would impact AV synchrony. Patients with pacing indications who plan to receive Micra AV implantation will be recruited.
This study will enroll up to 40 subjects in site. Patients with pacing indications who plan to receive Micra AV implantation will be selected.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
It is a observational study and patients with pacing indications who plan to receive Micra AV implantation will be recruited. No intervention procedure will be performed.
Assessment of ECG characteristics in relation to Micra tip location
Patients' ECG will be measured to see whether there is difference in ECG characteristics between Micra tip locations.
Time frame: Within 6 months after the surgery.
Cardiac functional changes
LVEF, RV length and quantity of tricuspid regurgitation will be measured.
Time frame: Within 6 months after the surgery.
To investigate whether Micra location would impact AV synchrony
Percentage of AV synchrony will be measured.
Time frame: Within 6 months after the surgery.
Plan to share: No
Ran from Jun 2025 to primary completion in Jul 2026, 12 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Aug 2026 → Jul 2026 and completion Aug 2026 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medtronic Cardiac Rhythm and Heart Failure →